Back
Gilead Sciences Vs. Nebius Group NV Industry Stock Comparison
Buy
54
GILD
Gilead Sciences
Last Price:
91.54
Seasonality Move:
8.17%
Buy
56
NBIS
Nebius Group NV
Last Price:
32.30
Seasonality Move:
-3.07%
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $92.49. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
- The current Nebius Group NV [NBIS] share price is $29.33. The Score for NBIS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $92.49
The current trend is moderately bullish and GILD is experiencing selling pressure, which indicates risk of future bearish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $29.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | -5342738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.51 - 94.17) | Buy |
| Bollinger Bands (100): | (75.66 - 89.5) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.49 | Buy |
| Relative Strength Index (14 RSI): | 73.79 | Buy |
| Chaikin Money Flow: | 15634228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.72 - 23.76) | Buy |
| Bollinger Bands (100): | (17.87 - 21.23) | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.66 | Buy |
| 20-day SMA: | 91.95 | Buy |
| 50-day SMA: | 88.39 | Buy |
| 200-day SMA: | 75.66 | Buy |
| 8-day EMA: | 92 | Buy |
| 20-day EMA: | 91.12 | Buy |
| 50-day EMA: | 88.22 | Buy |
| 200-day EMA: | 79.81 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.7 | Buy |
| 20-day SMA: | 21.15 | Buy |
| 50-day SMA: | 20.15 | Buy |
| 200-day SMA: | 19.24 | Buy |
| 8-day EMA: | 24.07 | Buy |
| 20-day EMA: | 22.09 | Buy |
| 50-day EMA: | 20.68 | Buy |
| 200-day EMA: | 19.53 | Buy |
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.36 per share, and an increase next year of $3.09 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gilead Sciences Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||